CL2012001333A1 - Method to identify the simultaneous presence of the elite events ee-gm1 and ee-gm3 or ee-gm2 and ee-gm3 in biological samples, based on the use of specific primers or probes, kit that includes said molecules, method to confirm purity of seeds." - Google Patents

Method to identify the simultaneous presence of the elite events ee-gm1 and ee-gm3 or ee-gm2 and ee-gm3 in biological samples, based on the use of specific primers or probes, kit that includes said molecules, method to confirm purity of seeds."

Info

Publication number
CL2012001333A1
CL2012001333A1 CL2012001333A CL2012001333A CL2012001333A1 CL 2012001333 A1 CL2012001333 A1 CL 2012001333A1 CL 2012001333 A CL2012001333 A CL 2012001333A CL 2012001333 A CL2012001333 A CL 2012001333A CL 2012001333 A1 CL2012001333 A1 CL 2012001333A1
Authority
CL
Chile
Prior art keywords
identify
biological samples
probes
kit
simultaneous presence
Prior art date
Application number
CL2012001333A
Other languages
Spanish (es)
Inventor
Mark Alan Eby
William H Eby
Gunter Welz
Steven Verhaeghe
Justin-Thomas Mason
Leslie-James Lettow
De-Beuckel
Original Assignee
Bayer Cropscience N V Ms Tech Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Cropscience N V Ms Tech Llc filed Critical Bayer Cropscience N V Ms Tech Llc
Publication of CL2012001333A1 publication Critical patent/CL2012001333A1/en

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pretreatment Of Seeds And Plants (AREA)

Abstract

Método para identificar la presencia simultánea de los eventos elite EE-GM3 y EE-GM1 en muestras biológicas que comprende detectar una región EE-GM3 con cebador o sonda; kit para identificar la presencia simultánea del evento elite EE-GM3 y evento elite EE-GM1 en muestras biológicas; par de cebadores; par de sondas; método para confirmar pureza de semillas.Method to identify the simultaneous presence of the elite events EE-GM3 and EE-GM1 in biological samples that comprises detecting an EE-GM3 region with primer or probe; kit to identify the simultaneous presence of the elite event EE-GM3 and elite event EE-GM1 in biological samples; pair of primers; pair of probes; method to confirm seed purity.

CL2012001333A 2009-11-23 2012-05-23 Method to identify the simultaneous presence of the elite events ee-gm1 and ee-gm3 or ee-gm2 and ee-gm3 in biological samples, based on the use of specific primers or probes, kit that includes said molecules, method to confirm purity of seeds." CL2012001333A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26370709P 2009-11-23 2009-11-23
EP09014565 2009-11-23
US36725110P 2010-07-23 2010-07-23

Publications (1)

Publication Number Publication Date
CL2012001333A1 true CL2012001333A1 (en) 2013-01-04

Family

ID=69650473

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2012001333A CL2012001333A1 (en) 2009-11-23 2012-05-23 Method to identify the simultaneous presence of the elite events ee-gm1 and ee-gm3 or ee-gm2 and ee-gm3 in biological samples, based on the use of specific primers or probes, kit that includes said molecules, method to confirm purity of seeds."

Country Status (3)

Country Link
BR (1) BR112012012567A2 (en)
CL (1) CL2012001333A1 (en)
UA (1) UA114171C2 (en)

Also Published As

Publication number Publication date
BR112012012567A2 (en) 2020-08-11
UA114171C2 (en) 2017-05-10

Similar Documents

Publication Publication Date Title
ECSP17025787A (en) USE OF FGFR MUTANT GENE PANELS IN IDENTIFYING CANCER PATIENTS WHO WILL RESPOND TO TREATMENT WITH AN FGFR INHIBITOR
BR112018069849A2 (en) kit, device and method for the detection of early pancreatic cancer or pancreatic cancer precursor lesion
EA201600085A1 (en) KIT FOR DETECTION OF SOYO SYNT SYNT0H2 EVENT
PH12018550037A1 (en) Quencher containing water-soluble polymer-conjugated nanomaterial and use thereof
AR096319A2 (en) METHOD AND KIT OF DETECTION OF DNA IN A SAMPLE THAT INCLUDES CORN DNA AND PROBE OF USEFUL DNA IN SUCH METHOD
ES2570632T3 (en) In vitro leukocyte elastase inhibitor determination procedure for colorectal cancer
CO6680668A2 (en) Biomarker assays to detect or measure inhibition of tor kinase activity
CL2013001338A1 (en) Compounds derived from substituted benzothiene-pyridines, hiv replication inhibitors; pharmaceutical composition that includes them; pharmaceutical combination; pharmaceutical kit; and its use for the treatment of hiv.
ECSP13013092A (en) TEST OF LISYLOXIDASE-HOMOLOGIST 2 AND METHODS OF USE OF THE SAME
CL2019002438A1 (en) Use of biomarkers in the identification of cancer patients who will be sensitive to treatment with a prmt5 inhibitor.
CL2012002904A1 (en) Combination or pharmaceutical composition comprising an inhibitor of cell signaling and / or angiogenesis and an aurora kinase inhibitor (aki); pharmaceutical kit that includes it; its use in the treatment of oncological and fibrotic diseases; and substituted indole and pyrimidine compounds.
ES2674177T3 (en) Serum preparation
EA201490948A1 (en) METHOD FOR DETERMINING COMPLIANCE WITH HYGIENE OF HANDS
GT201000037A (en) CYCLIC DEPSIPEPTIDES
CL2017002101A1 (en) Device, platform and assay for cell evaluation
AR087363A1 (en) USE OF ANTIBODY I-3859 FOR THE DETECTION AND DIAGNOSIS OF CANCERES
CL2012002347A1 (en) In vitro method for the diagnosis of dementia with lewy bodies (lbd), which comprises determining in a biological sample of an individual the genotype of the following alterations in the butyrylcholinesterase gene or of polymorphisms in their union imbalance; kit for carrying out said method; use of the lbd diagnostic kit.
AR076113A1 (en) METHOD OR SYSTEM THAT USES BIOMARKERS TO FOLLOW A TREATMENT
AR072425A1 (en) USE OF NIFURTIMOX FOR THE TREATMENT OF GIARDIASIS
AR072426A1 (en) USE OF NIFURTIMOX FOR THE TREATMENT OF DISEASES CAUSED BY TRICOMONADIDA
SG168423A1 (en) Influenza detection method and kit therefor
CY1121482T1 (en) SENSITIVE MULTIPLECTUAL IMMODIATION FOR SOLVENT RECEPTORS OF INFLASTIC GROWTH FACTORS
CL2016002380A1 (en) Cleaning device for medical instruments and related methods of use.
AR103745A1 (en) HOMOGENOUS IMMUNOENSAY WITH COMPENSATION OF THE FUND SIGNAL
CL2011000248A1 (en) Method to increase growth or differentiation in vitro in a cell or tissue culture, based on the application of pulsed radio frequency (prf); and use of said treatment.